High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: A clinical and serologic study

American Journal of the Medical Sciences

Volumn 331, Issue 1, 2006, Pages 4-9

  Sthoeger, Zev ^a,b,c   Neiman, Alexander ^a   Elbirt, Daniel ^a   Zinger, Hiedy ^b   Magen, Eli ^a   Burstein, Rimona ^a   Eitan, Sara ^a   Abarbanel, Jakov ^c   Mozes, Edna ^b  

^a HEBREW UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c KAPLAN MEDICAL CENTER   (Israel)

Author keywords

ds DNA antibodies; Myasthenia gravis; Systemic lupus erythematosus; Thymectomy

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DOUBLE STRANDED DNA ANTIBODY;

ADULT; AGED; ANAMNESIS; ARTICLE; CLINICAL STUDY; COLLEGE; COMORBIDITY; DATA BASE; DISEASE ASSOCIATION; EVALUATION; FEMALE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; PHYSICAL EXAMINATION; PREVALENCE; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMECTOMY;

EID: 31744447943     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200601000-00004     Document Type: Article

References (23)

1. Chan MK, Britton M. Comparative clinical features in patients with myasthenia gravis with systemic lupus erythematosus. J Rheumatol 1980;7:838-42.
2. Goldman M, Herode A, Borenstein S, et al. Optic neuritis, transverse myelitis, and anti-DNA antibodies nine years after thymectomy for myasthenia gravis. Arthritis Rheum 1984;27:701-3.
3. Ben-Chetrit E, Pollack A, Flusser D, et al. Coexistence of systemic lupus erythematosus and myasthenia gravis: two distinct populations of anti-DNA and anti-acetylcholine receptor antibodies. Clin Exp Rheumatol 1990;8:71-4.
4. Grinlinton FM, Lynch NM, Hart HH. A pair of monozygotic twins who are concordant for myasthenia gravis but became discordant for systemic lupus erythematosus post-thymectomy. Arthritis Rheum 1991;34:916-9.
5. Vaiopoulos G, Sfikakis PP, Kapsimali V, et al. The association of systemic lupus erythematosus and myasthenia gravis. Postgrad Med J 1994;70:741-5.
6. Mevorach D, Perrot S, Buchanan NM, et al. Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature. Lupus 1995;4:33-7.
7. Barbosa RE, Cordova S, Cajigas JC. Coexistence of systemic lupus erythematosus and myasthenia gravis. Lupus 2000;9:156-7.
8. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330: 1797-1810.
9. Mantegazza R, Beghi E, Pareyson D, et al. A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J Neurol 1990;237:339-44.
10. Hahn BH. An overview of the pathogenesis of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. Philadelphia: Lippincott Williams & Wilkins; 1993. p. 69-76.
11. Winchester RJ. Systemic lupus erythematosus pathogenesis. In: Koopman WJ, editor. Arthritis and Allied Conditions. Baltimore: Lippincott Williams & Wilkins; 1996. p. 1361-91.
12. Sthoeger ZM, Dayan M, Tcherniack A, et al. Modulation of autoreactive responses of peripheral blood lymphocytes of patients with systemic lupus erythematosus by peptides based on human and murine anti-DNA autoantibodies. Clin Exp Immunol 2003;131:385-92.
13. Osterhuis HJ. Obsevations of the natural history of myasthenia gravis and the effect of thymectomy. Ann N Y Acad Sci 1981;377:678-90.
14. Thorlacius S, Aarli JA, Riise T, et al. Associated disorders in myasthenia gravis: autoimmune disease and their relation to thymectomy. Acta Neurol Scand 1989;80:290-5.
15. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
16. Tan EM. Antibodies to nuclear antigens: their biology and medicine. Adv Immunol 1982;33:167-240.
17. Sthoeger Z, Zinger H, Dekel B, et al. Lupus manifestations in severe combined immunodeficient (SCID) mice and in human/mouse radiation chimeras. J Clin Immunol 2003;23:91-9.
18. Potagas C, Dellatolas G, Tavernarakis A, et al. Myasthenia gravis: changes observed in a 30-years retrospective clinical study of a hospital-based population. J Neurol 2004;251:116-7.
19. Hochberg MC. Epidemiology of systemic lupus erythematosus. In: Lahita RG, editor. Systemic lupus erythematosus. 2nd ed. New York: Churchill Livingstone; 1992. p. 103-71.
20. Weiss P, Shoenfeld Y. Shifts in autoimmune diseases: the kaleidoscope of autoimmunity. Isr J Med Sci 1991;27:216-7.
21. Steinberg AD, Law LD, Talal N. The role of NZB-NZW F1 thymus in experimental tolerance and auto-immunity. Arthritis Rheum 1970;13:369-77.
22. West SG, Emlen W, Wener MH, et al. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med 1995;99:153-63.
23. Isshi K, Hirohata S. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 1998;41:1819-27.